Segment Information (Tables)

9 Months Ended

Sep. 30, 2019

Segment Reporting [Abstract]

Summary of Net sales and Operating Profit by Segment

Net sales and operating profit by segment are as follows (in millions):

	Net Sales				Operating Profit
	Three Months Ended				Three Months Ended
	September 30,				September 30,
	2019		2018		2019			2018
Americas	$	961.2	$	934.5	$	517.3		$	493.7
EMEA		330.9		326.8		91.8			84.7
Asia Pacific		322.6		295.9		106.3			93.3
Product Category Operating Segments		277.7		279.5		39.1			42.7
Global Operations and Corporate Functions		-		-		(253.5	)		(243.4	)
Total	$	1,892.4	$	1,836.7
Inventory and manufacturing-related charges						(11.6	)		(5.0	)
Intangible asset amortization						(146.6	)		(147.6	)
Intangible asset impairment						-			(3.8	)
Acquisition, integration and related						0.9			(17.4	)
Quality remediation						(21.5	)		(34.2	)
Litigation						(42.8	)		(14.0	)
European Union Medical Device Regulation						(11.4	)		(0.8	)
Other charges						(22.2	)		(24.9	)
Operating profit					$	245.8		$	223.3

	Net Sales				Operating Profit
	Nine Months Ended				Nine Months Ended
	September 30,				September 30,
	2019		2018		2019			2018
Americas	$	2,925.7	$	2,904.9	$	1,563.2		$	1,556.0
EMEA		1,120.0		1,159.4		335.1			341.4
Asia Pacific		948.2		914.0		325.1			305.1
Product Category Operating Segments		862.6		883.6		129.7			135.3
Global Operations and Corporate Functions		-		-		(781.9	)		(733.5	)
Total	$	5,856.5	$	5,861.9
Inventory and manufacturing-related charges						(47.7	)		(24.7	)
Intangible asset amortization						(436.9	)		(447.9	)
Intangible asset impairment						(70.1	)		(3.8	)
Acquisition, integration and related						(20.3	)		(113.9	)
Quality remediation						(64.6	)		(125.8	)
Litigation						(48.0	)		(15.5	)
Litigation settlement gain						23.5			-
European Union Medical Device Regulation						(18.1	)		(1.6	)
Other charges						(88.3	)		(46.8	)
Operating profit					$	800.7		$	824.3